| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 117,962 | 113,580 | 109,602 | 137,783 | | Cost of Revenue | 114,855 | 108,998 | 106,027 | 138,656 | | | Gross Profit | 3,107 | 4,582 | 3,575 | (873) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,533 | 6,841 | 5,948 | 8,044 | | Non Recurring | 1,731 | 717 | 792 | 29,690 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,157) | (2,976) | (3,165) | (12,259) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | (3,392) | 221 | 25,659 | | Earnings Before Interest And Taxes | (12,937) | (6,368) | (2,944) | (3,956) | | Interest Expense | (9,062) | 4,790 | 4,272 | 4,498 | | Income Before Tax | (3,875) | (11,158) | (7,216) | 11,956 | | Income Tax Expense | (527) | 263 | 360 | (366) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,202) | (11,083) | (7,235) | (16,886) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (12) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,202) | (11,083) | (7,235) | (16,898) | | Preferred Stock And Other Adjustments | (3,497) | (3,432) | (3,363) | (3,298) | | | Net Income Applicable To Common Shares | ($10,699) | ($14,515) | ($10,598) | ($20,196) |
|
0.37% Nasdaq 
Income Statement
